Immunothérapie sublinguale pourle traitement de la rhinoconjonctivite et l’asthme allergique : guide pratique [Sublingual immunotherapy for the treatment of allergic rhinoconjonctivitis and asthma : a practical approach]

Details

Serval ID
serval:BIB_344CEBAEFAA6
Type
Article: article from journal or magazin.
Publication sub-type
Review (review): journal as complete as possible of one specific subject, written based on exhaustive analyses from published work.
Collection
Publications
Institution
Title
Immunothérapie sublinguale pourle traitement de la rhinoconjonctivite et l’asthme allergique : guide pratique [Sublingual immunotherapy for the treatment of allergic rhinoconjonctivitis and asthma : a practical approach]
Journal
Revue medicale suisse
Author(s)
Ghosn J., Spertini F., Comte D.
ISSN
1660-9379 (Print)
ISSN-L
1660-9379
Publication state
Published
Issued date
04/04/2018
Peer-reviewed
Oui
Volume
14
Number
601
Pages
735-739
Language
french
Notes
Publication types: English Abstract ; Journal Article
Publication Status: ppublish
Abstract
The prevalence of allergic diseases has been increasing over the past 50 years, leading to social and economic consequences. Immunotherapy is the only disease-modifying therapy available for allergic diseases, with durable long-term benefits. Immunotherapy is primarily available in two forms : 1) subcutaneous injections or 2) sublingual tablets/drops. The latter offers the advantage of being managed by the patient himself, requires no injections and has a far lower risk of severe systemic adverse events. In Switzerland, the use of sublingual immunotherapy is still scarce. This article reviews the indications, the administration technics and the contraindications to sublingual immunotherapy.

Pubmed
Create date
14/04/2018 10:53
Last modification date
20/08/2019 13:20
Usage data